C5a has been shown to promote IL-22 and IL-17 expression from CD4+ T-cells derived from AMD patients47, and C5a has been shown to promote production of another cytokine, IL-865, as well as VEGF66, by ARPE-19 cells. This evidence concerns the gene C5 and age-related macular degeneration.